期刊文献+

新城疫病毒在肿瘤治疗中的研究进展 被引量:2

Progress on Newcastle Disease Virus in Tumor Therapy
下载PDF
导出
摘要 新城疫病毒(NDV)是一种新兴的肿瘤生物治疗因子,反向遗传学操作技术的成熟使其在肿瘤治疗中的应用研究越来越深入。NDV能够通过其直接的溶瘤作用杀死肿瘤细胞,也可通过感染自体肿瘤细胞制成疫苗对患者进行主动特异性免疫治疗。但直接溶瘤效应会对患者产生一定的负面影响,自体肿瘤疫苗的免疫治疗也不能彻底杀死肿瘤细胞。目前,以NDV为复制型病毒载体的肿瘤基因治疗已成为该病毒肿瘤生物治疗的研究热点,这种基因治疗方法被认为是人类征服癌症的潜在手段。论文综述了NDV在肿瘤治疗中的研究与应用,对其溶瘤及抗肿瘤免疫学机制进行了分析,并对NDV作为载体的肿瘤基因治疗前景进行展望。 Newcastle disease virus (NDV) is a new tumor biological treatment factor, and it has been in- creasingly applieated in oncotherapy with the development of reverse genetics operation technology. NDV kills tumor cells directly by its oncolytic functions; it also was used in active specific immune therapy by NDV-modified autologous tumor vaccine. Killing tumor cells directly cause negative effect to physical health, immune therapy by autologous tumor vaccine can't kill tumor cells thoroughly. At present, gene therapy with NDV as vector has become hot research areas in tumor biotherapy, gene therapy way is also thought to be potential effective means to conquer cancer. The paper reviewed the research and application of NDV in cancer therapy, elucidated the mechanisms of NDV as oncolytic virus and as NDV-modified au- tologous tumor vaccine, and finally prospected its application in cancer gene therapy as a vector.
作者 李亚琳
出处 《动物医学进展》 CSCD 北大核心 2012年第8期97-100,共4页 Progress In Veterinary Medicine
基金 陕西省教育厅资助项目(009JK427) 渭南师范学院基金资助项目(10YKZ054)
关键词 新城疫病毒 基因治疗 肿瘤 Newcastle disease virus gene therapy tumor
  • 相关文献

参考文献24

  • 1Ravindra P V, Tiwari A K, Sharma B, et al. Newcastle dis- ease virus as an oncolytic agent[J]. Indian J Med Res, 2009, 130(5) : 507-513.
  • 2Krishnamurthy S, Takimoto T, Scroggs R A, et al. Differen- tially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines [J].J Virol, 2006, 80: 5145-5155.
  • 3Fiola C,Peeters B, Fournier P, et al. Tumor selective replica- tion of Newcastle disease virus: Association with de{cots o{ tumor cells in antiviral defence[J]. Int J Cancer, 2006, 119 (2) .. 328-338.
  • 4Park M S, Garcia Sastre A, Cros J F, et al. Newcastle disease virus V protein is a determinant of host range restriction J. J Virol, 2003, 77(17): 9522-9532.
  • 5Mansour M, Palese P, Zamarin D. Oncolytie specificity of Newcastle disease virus is mediated by selectivity for apoptosis resistant cells[J]. J Virol, 2011, 85(12) : 6015-6023.
  • 6Fournier P, Bian H, Szeber6nyi J, et al. Analysis of three properties of newcastle disease virus for fighting cancer: tumor- selective replication, antitumor cytotoxicity, and immunostim ulation[J]. Methods Mol Biol, 2012, 797.- 177 204.
  • 7孙迎春,金宁一,米志强,李霄,连海,李萍.新城疫病毒HN基因诱导肝癌细胞SMMC7721凋亡的作用机制[J].中华肿瘤杂志,2005,27(5):279-282. 被引量:5
  • 8Fabian Z, Csatary C M, Szeberenyi J, et al. P53-independen endoplasmic reticulum stress-mediated cytotoxieity of a New castle disease virus strain in tumor cell lines[J]. J Virol, 2007 81(6).. 2817-2830.
  • 9Bian J, Wang K, Kong X, et al. Caspase- and p38-MAPK-de pendent induction of apoptosis in A549 lung cancer cells b' Newcastle disease virus[J]. Arch Virol, 2011, 156(8).. 1335 1344.
  • 10Wu Y, Zhang X, Wang X, et al. Apoptin enhances the onco- lytic properties of newcastle disease virus[J]. Intervirology, 2012, 55: 276-286.

二级参考文献13

  • 1Powell LD, Whiteheart SW, Hart GW. Cell surface sialic acid influences tumor cell recognition in the mixed lymphocyte reaction. J Immunol, 1987, 139: 262-270.
  • 2Schirramacher V, Hass C, Bonifer R, et al. Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus. Gene Ther, 1999, 6: 63-73.
  • 3Rondla M1, Gisela MF, Jennifer MS, et al. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease Vires hemagglutinin-neruaminidase protein:receptor recognition is dependent on neuramindase activity. Journal of Virology, 2001, 75: 1981-1987.
  • 4Yoshihiro S, Noriaki N. Hisataka M, et al. Rapid loss in the mitochondria membrane potential during geranylgeranoic acid-induced apoptosis. Biochem Biophys Res Common, 1997, 230: 58-63.
  • 5Termeer CC, Schirrmacher V, Brocker EB, et al. Newcastle disease virus infection induces B7-1/B7-2 independent T-cell costimulatory activity in human melanoma cells. Cancer Gene Ther, 2000, 7: 316-323.
  • 6Steock M, Marland-Noske C, Manasterki M, et al. In vitro expansion and analysis of T lymphocyte microcultures obtained from active specific immunization with autologous Newcastle-disease-virus-modified tumor cells. Cancer Immunol Immunother, 1993, 37: 240-244.
  • 7Reichard KW, Lorence RM, Cassino CJ. et al. Selective replication of Newcastle disease virus(NDV) in cancer cells is associated with virus-induced cell fusion. Proc Am Assoc Cancer Res, 1992, 33: 521-530.
  • 8Wickremasinghe RG, Hofflbrand AV. Biochemical and genetic control of apoptosis: relevance to normal hematopoiesis and hematological malignancies. Blood, 1999, 18: 44-50.
  • 9Reed JC. Cytochrome c: can't live with it-can't live without it. Cell,1997, 91: 559-562.
  • 10李瑛,石廷章,赵卫红.泰素帝诱导人肺腺癌细胞凋亡的实验研究[J].中华肿瘤杂志,2000,22(3):208-211. 被引量:34

共引文献4

同被引文献27

  • 1吴小锋,曹翠平,鲁兴萌.昆虫杆状病毒表达系统中重组蛋白质的降解及其对策[J].蚕业科学,2005,31(4):382-388. 被引量:7
  • 2McGregor DD, Logie PS, Carmichael LE. The mediator of cellular immunity. Ⅻ. Inhibition of activated T cells by Newcastle disease virus[J].J Exp Med, 1976, 144(3): 627-643.
  • 3F~bi~tn Z, Csatary CM, Szeber6nyi J, et al. pS3-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines[J]. J Virol, 2007, 81(6): 2817-2830.
  • 4Bai T, Lian LH, Wu YL, et al. Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells [J]. Int Immunopharmacol, 2013, 15 (2): 275-281.
  • 5Kaji K, Yoshiji H, Ikenaka Y, et al. Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats[J]. J Gastroenterol, 2013, [Epub ahead of print].
  • 6Akpolat N, Yahsi S, Godekmerdan A, et al. The value of α -SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathotogical and immunohistochemical study[J]. Histopathology, 2005, 47(3): 276-280.
  • 7Dong R, Luo Y, Zheng S. α -SMA overexpression associated with increased liver fibrosis in infants with biliary atresia[J]. J Pediatr Gastroenterol Nutr, 2012, 55(6): 653-656.
  • 8Mak KM, Chu E, Lau KH, et al. Liver fibrosis in elderly cadavers: localization of collagen types Ⅰ , Ⅲ and Ⅳ, ot -smooth muscle actin, and elastic fibers[J]. Anat Rec (Hoboken), 2012, 295(7): 1159-1167.
  • 9Hu Z, Hu J, Hu S, et al. Strong innate immune response and cell death in chicken splenocytes infected with genotype Vlld Newcastle disease virus[J]. VirolJ, 2012, 9: 208.
  • 10Schmidt MR, McGinnes LW, Kenward SA, et al. Long-term and memory immune responses in mice against Newcastle disease virus-like particles containing respiratory syncytial virus glycoprotein ectodomains[J].J Virol, 2012, 86(21 ): 11654-11667.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部